Quantitative PCR (qPCR) enables high-throughput assessment of Fn DNA across large cohorts, supporting tumor enrichment relative to non-tumor controls and associations with poorer survival in colorectal, gastric, head and neck, and pancreatic cancers [4,8,13,14]. Here, FN1 is linked to neoplasm.